Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis
Trials examining the benefit of thrombectomy in anterior circulation proximal large vessel occlusion stroke have enrolled patients considered to have salvageable brain tissue, who were randomly assigned beyond 6 h and (depending on study protocol) up to 24 h from time last seen well. We aimed to est...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2022-01, Vol.399 (10321), p.249-258 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 258 |
|---|---|
| container_issue | 10321 |
| container_start_page | 249 |
| container_title | The Lancet (British edition) |
| container_volume | 399 |
| creator | Jovin, Tudor G Nogueira, Raul G Lansberg, Maarten G Demchuk, Andrew M Martins, Sheila O Mocco, J Ribo, Marc Jadhav, Ashutosh P Ortega-Gutierrez, Santiago Hill, Michael D Lima, Fabricio O Haussen, Diogo C Brown, Scott Goyal, Mayank Siddiqui, Adnan H Heit, Jeremy J Menon, Bijoy K Kemp, Stephanie Budzik, Ron Urra, Xabier Marks, Michael P Costalat, Vincent Liebeskind, David S Albers, Gregory W |
| description | Trials examining the benefit of thrombectomy in anterior circulation proximal large vessel occlusion stroke have enrolled patients considered to have salvageable brain tissue, who were randomly assigned beyond 6 h and (depending on study protocol) up to 24 h from time last seen well. We aimed to estimate the benefit of thrombectomy overall and in prespecified subgroups through individual patient data meta-analysis.
We did a systematic review and individual patient data meta-analysis between Jan 1, 2010, and March 1, 2021, of randomised controlled trials of endovascular stroke therapy. In the Analysis Of Pooled Data From Randomized Studies Of Thrombectomy More Than 6 Hours After Last Known Well (AURORA) collaboration, the primary outcome was disability on the modified Rankin Scale (mRS) at 90 days, analysed by ordinal logistic regression. Key safety outcomes were symptomatic intracerebral haemorrhage and mortality within 90 days.
Patient level data from 505 individuals (n=266 intervention, n=239 control; mean age 68·6 years [SD 13·7], 259 [51·3%] women) were included from six trials that met inclusion criteria of 17 screened published randomised trials. Primary outcome analysis showed a benefit of thrombectomy with an unadjusted common odds ratio (OR) of 2·42 (95% CI 1·76–3·33; p |
| doi_str_mv | 10.1016/S0140-6736(21)01341-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2597814656</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673621013416</els_id><sourcerecordid>2597814656</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-bc596232d5bf14cecb73b0416e5389b0ee43c294574bb9e457c665d17414a9e03</originalsourceid><addsrcrecordid>eNqFkctq3DAUhkVpaaZpH6FF0M1k4VayJdnuJgyhNwgE0gS6E7ocEyW2NJXkDH6Uvm01mTSLbro6An3nl875EHpLyQdKqPj4g1BGKtE2Yl3TE0IbRivxDK0oa1nFWfvzOVo9IUfoVUq3hBAmCH-JjhrWtoz23Qr9vrqJYdJgcpgWPISIlc8QXTkYF808quyCxynHcAdYwxK8xQLf4KG04ewmwKNKGd_5sPN4B-OI15vry4vLzcknrHBaUoapZBgc4d7BrsRb7Lx1987OasTbcgc-Y6uywhNkVSmvxiW59Bq9GNSY4M1jPUbXXz5fnX2rzi--fj_bnFeG1SJX2vBe1E1tuR4oM2B022jCqADedL0mAKwxdc94y7TuoVQjBLe0zM9UD6Q5RutD7jaGXzOkLCeXTBlEeQhzkjXv244ywUVB3_-D3oY5lv8WStCe046LrlD8QJkYUoowyG10k4qLpETu3ckHd3IvRtZUPriT-_R3j-mznsA-df2VVYDTAwBlHWWZUSZTlmfAulgEShvcf574A_ePqdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2619518568</pqid></control><display><type>article</type><title>Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Jovin, Tudor G ; Nogueira, Raul G ; Lansberg, Maarten G ; Demchuk, Andrew M ; Martins, Sheila O ; Mocco, J ; Ribo, Marc ; Jadhav, Ashutosh P ; Ortega-Gutierrez, Santiago ; Hill, Michael D ; Lima, Fabricio O ; Haussen, Diogo C ; Brown, Scott ; Goyal, Mayank ; Siddiqui, Adnan H ; Heit, Jeremy J ; Menon, Bijoy K ; Kemp, Stephanie ; Budzik, Ron ; Urra, Xabier ; Marks, Michael P ; Costalat, Vincent ; Liebeskind, David S ; Albers, Gregory W</creator><creatorcontrib>Jovin, Tudor G ; Nogueira, Raul G ; Lansberg, Maarten G ; Demchuk, Andrew M ; Martins, Sheila O ; Mocco, J ; Ribo, Marc ; Jadhav, Ashutosh P ; Ortega-Gutierrez, Santiago ; Hill, Michael D ; Lima, Fabricio O ; Haussen, Diogo C ; Brown, Scott ; Goyal, Mayank ; Siddiqui, Adnan H ; Heit, Jeremy J ; Menon, Bijoy K ; Kemp, Stephanie ; Budzik, Ron ; Urra, Xabier ; Marks, Michael P ; Costalat, Vincent ; Liebeskind, David S ; Albers, Gregory W</creatorcontrib><description>Trials examining the benefit of thrombectomy in anterior circulation proximal large vessel occlusion stroke have enrolled patients considered to have salvageable brain tissue, who were randomly assigned beyond 6 h and (depending on study protocol) up to 24 h from time last seen well. We aimed to estimate the benefit of thrombectomy overall and in prespecified subgroups through individual patient data meta-analysis.
We did a systematic review and individual patient data meta-analysis between Jan 1, 2010, and March 1, 2021, of randomised controlled trials of endovascular stroke therapy. In the Analysis Of Pooled Data From Randomized Studies Of Thrombectomy More Than 6 Hours After Last Known Well (AURORA) collaboration, the primary outcome was disability on the modified Rankin Scale (mRS) at 90 days, analysed by ordinal logistic regression. Key safety outcomes were symptomatic intracerebral haemorrhage and mortality within 90 days.
Patient level data from 505 individuals (n=266 intervention, n=239 control; mean age 68·6 years [SD 13·7], 259 [51·3%] women) were included from six trials that met inclusion criteria of 17 screened published randomised trials. Primary outcome analysis showed a benefit of thrombectomy with an unadjusted common odds ratio (OR) of 2·42 (95% CI 1·76–3·33; p<0·0001) and an adjusted common OR (for age, gender, baseline stroke severity, extent of infarction on baseline head CT, and time from onset to random assignment) of 2·54 (1·83–3·54; p<0·0001). Thrombectomy was associated with higher rates of independence in activities of daily living (mRS 0–2) than best medical therapy alone (122 [45·9%] of 266 vs 46 [19·3%] of 238; p<0·0001). No significant difference between intervention and control groups was found when analysing either 90-day mortality (44 [16·5%] of 266 vs 46 [19·3%] of 238) or symptomatic intracerebral haemorrhage (14 [5·3%] of 266 vs eight [3·3%] of 239). No heterogeneity of treatment effect was noted across subgroups defined by age, gender, baseline stroke severity, vessel occlusion site, baseline Alberta Stroke Program Early CT Score, and mode of presentation; treatment effect was stronger in patients randomly assigned within 12–24 h (common OR 5·86 [95% CI 3·14–10·94]) than those randomly assigned within 6–12 h (1·76 [1·18–2·62]; pinteraction=0·0087).
These findings strengthen the evidence for benefit of endovascular thrombectomy in patients with evidence of reversible cerebral ischaemia across the 6–24 h time window and are relevant to clinical practice. Our findings suggest that in these patients, thrombectomy should not be withheld on the basis of mode of presentation or of the point in time of presentation within the 6–24 h time window.
Stryker Neurovascular.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(21)01341-6</identifier><identifier>PMID: 34774198</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Activities of daily living ; Age ; Cardiovascular system ; Cerebral blood flow ; Cerebral Hemorrhage - epidemiology ; Cerebral Hemorrhage - etiology ; Cerebral infarction ; Clinical medicine ; Clinical trials ; Data analysis ; Endovascular Procedures - adverse effects ; Endovascular Procedures - methods ; Endovascular Procedures - statistics & numerical data ; Estimates ; Gender ; Health services ; Hemorrhage ; Heterogeneity ; Humans ; Ischemia ; Meta-analysis ; Mortality ; Occlusion ; Patients ; Postoperative Hemorrhage - epidemiology ; Postoperative Hemorrhage - etiology ; Randomized Controlled Trials as Topic ; Stroke ; Subgroups ; Systematic review ; Thrombectomy - adverse effects ; Thrombectomy - methods ; Thrombectomy - statistics & numerical data ; Thrombotic Stroke - mortality ; Thrombotic Stroke - surgery ; Time-to-Treatment ; Treatment Outcome ; Windows (intervals)</subject><ispartof>The Lancet (British edition), 2022-01, Vol.399 (10321), p.249-258</ispartof><rights>2022 Elsevier Ltd</rights><rights>Copyright © 2022 Elsevier Ltd. All rights reserved.</rights><rights>2022. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-bc596232d5bf14cecb73b0416e5389b0ee43c294574bb9e457c665d17414a9e03</citedby><cites>FETCH-LOGICAL-c426t-bc596232d5bf14cecb73b0416e5389b0ee43c294574bb9e457c665d17414a9e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0140673621013416$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34774198$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jovin, Tudor G</creatorcontrib><creatorcontrib>Nogueira, Raul G</creatorcontrib><creatorcontrib>Lansberg, Maarten G</creatorcontrib><creatorcontrib>Demchuk, Andrew M</creatorcontrib><creatorcontrib>Martins, Sheila O</creatorcontrib><creatorcontrib>Mocco, J</creatorcontrib><creatorcontrib>Ribo, Marc</creatorcontrib><creatorcontrib>Jadhav, Ashutosh P</creatorcontrib><creatorcontrib>Ortega-Gutierrez, Santiago</creatorcontrib><creatorcontrib>Hill, Michael D</creatorcontrib><creatorcontrib>Lima, Fabricio O</creatorcontrib><creatorcontrib>Haussen, Diogo C</creatorcontrib><creatorcontrib>Brown, Scott</creatorcontrib><creatorcontrib>Goyal, Mayank</creatorcontrib><creatorcontrib>Siddiqui, Adnan H</creatorcontrib><creatorcontrib>Heit, Jeremy J</creatorcontrib><creatorcontrib>Menon, Bijoy K</creatorcontrib><creatorcontrib>Kemp, Stephanie</creatorcontrib><creatorcontrib>Budzik, Ron</creatorcontrib><creatorcontrib>Urra, Xabier</creatorcontrib><creatorcontrib>Marks, Michael P</creatorcontrib><creatorcontrib>Costalat, Vincent</creatorcontrib><creatorcontrib>Liebeskind, David S</creatorcontrib><creatorcontrib>Albers, Gregory W</creatorcontrib><title>Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Trials examining the benefit of thrombectomy in anterior circulation proximal large vessel occlusion stroke have enrolled patients considered to have salvageable brain tissue, who were randomly assigned beyond 6 h and (depending on study protocol) up to 24 h from time last seen well. We aimed to estimate the benefit of thrombectomy overall and in prespecified subgroups through individual patient data meta-analysis.
We did a systematic review and individual patient data meta-analysis between Jan 1, 2010, and March 1, 2021, of randomised controlled trials of endovascular stroke therapy. In the Analysis Of Pooled Data From Randomized Studies Of Thrombectomy More Than 6 Hours After Last Known Well (AURORA) collaboration, the primary outcome was disability on the modified Rankin Scale (mRS) at 90 days, analysed by ordinal logistic regression. Key safety outcomes were symptomatic intracerebral haemorrhage and mortality within 90 days.
Patient level data from 505 individuals (n=266 intervention, n=239 control; mean age 68·6 years [SD 13·7], 259 [51·3%] women) were included from six trials that met inclusion criteria of 17 screened published randomised trials. Primary outcome analysis showed a benefit of thrombectomy with an unadjusted common odds ratio (OR) of 2·42 (95% CI 1·76–3·33; p<0·0001) and an adjusted common OR (for age, gender, baseline stroke severity, extent of infarction on baseline head CT, and time from onset to random assignment) of 2·54 (1·83–3·54; p<0·0001). Thrombectomy was associated with higher rates of independence in activities of daily living (mRS 0–2) than best medical therapy alone (122 [45·9%] of 266 vs 46 [19·3%] of 238; p<0·0001). No significant difference between intervention and control groups was found when analysing either 90-day mortality (44 [16·5%] of 266 vs 46 [19·3%] of 238) or symptomatic intracerebral haemorrhage (14 [5·3%] of 266 vs eight [3·3%] of 239). No heterogeneity of treatment effect was noted across subgroups defined by age, gender, baseline stroke severity, vessel occlusion site, baseline Alberta Stroke Program Early CT Score, and mode of presentation; treatment effect was stronger in patients randomly assigned within 12–24 h (common OR 5·86 [95% CI 3·14–10·94]) than those randomly assigned within 6–12 h (1·76 [1·18–2·62]; pinteraction=0·0087).
These findings strengthen the evidence for benefit of endovascular thrombectomy in patients with evidence of reversible cerebral ischaemia across the 6–24 h time window and are relevant to clinical practice. Our findings suggest that in these patients, thrombectomy should not be withheld on the basis of mode of presentation or of the point in time of presentation within the 6–24 h time window.
Stryker Neurovascular.</description><subject>Activities of daily living</subject><subject>Age</subject><subject>Cardiovascular system</subject><subject>Cerebral blood flow</subject><subject>Cerebral Hemorrhage - epidemiology</subject><subject>Cerebral Hemorrhage - etiology</subject><subject>Cerebral infarction</subject><subject>Clinical medicine</subject><subject>Clinical trials</subject><subject>Data analysis</subject><subject>Endovascular Procedures - adverse effects</subject><subject>Endovascular Procedures - methods</subject><subject>Endovascular Procedures - statistics & numerical data</subject><subject>Estimates</subject><subject>Gender</subject><subject>Health services</subject><subject>Hemorrhage</subject><subject>Heterogeneity</subject><subject>Humans</subject><subject>Ischemia</subject><subject>Meta-analysis</subject><subject>Mortality</subject><subject>Occlusion</subject><subject>Patients</subject><subject>Postoperative Hemorrhage - epidemiology</subject><subject>Postoperative Hemorrhage - etiology</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Stroke</subject><subject>Subgroups</subject><subject>Systematic review</subject><subject>Thrombectomy - adverse effects</subject><subject>Thrombectomy - methods</subject><subject>Thrombectomy - statistics & numerical data</subject><subject>Thrombotic Stroke - mortality</subject><subject>Thrombotic Stroke - surgery</subject><subject>Time-to-Treatment</subject><subject>Treatment Outcome</subject><subject>Windows (intervals)</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkctq3DAUhkVpaaZpH6FF0M1k4VayJdnuJgyhNwgE0gS6E7ocEyW2NJXkDH6Uvm01mTSLbro6An3nl875EHpLyQdKqPj4g1BGKtE2Yl3TE0IbRivxDK0oa1nFWfvzOVo9IUfoVUq3hBAmCH-JjhrWtoz23Qr9vrqJYdJgcpgWPISIlc8QXTkYF808quyCxynHcAdYwxK8xQLf4KG04ewmwKNKGd_5sPN4B-OI15vry4vLzcknrHBaUoapZBgc4d7BrsRb7Lx1987OasTbcgc-Y6uywhNkVSmvxiW59Bq9GNSY4M1jPUbXXz5fnX2rzi--fj_bnFeG1SJX2vBe1E1tuR4oM2B022jCqADedL0mAKwxdc94y7TuoVQjBLe0zM9UD6Q5RutD7jaGXzOkLCeXTBlEeQhzkjXv244ywUVB3_-D3oY5lv8WStCe046LrlD8QJkYUoowyG10k4qLpETu3ckHd3IvRtZUPriT-_R3j-mznsA-df2VVYDTAwBlHWWZUSZTlmfAulgEShvcf574A_ePqdA</recordid><startdate>20220115</startdate><enddate>20220115</enddate><creator>Jovin, Tudor G</creator><creator>Nogueira, Raul G</creator><creator>Lansberg, Maarten G</creator><creator>Demchuk, Andrew M</creator><creator>Martins, Sheila O</creator><creator>Mocco, J</creator><creator>Ribo, Marc</creator><creator>Jadhav, Ashutosh P</creator><creator>Ortega-Gutierrez, Santiago</creator><creator>Hill, Michael D</creator><creator>Lima, Fabricio O</creator><creator>Haussen, Diogo C</creator><creator>Brown, Scott</creator><creator>Goyal, Mayank</creator><creator>Siddiqui, Adnan H</creator><creator>Heit, Jeremy J</creator><creator>Menon, Bijoy K</creator><creator>Kemp, Stephanie</creator><creator>Budzik, Ron</creator><creator>Urra, Xabier</creator><creator>Marks, Michael P</creator><creator>Costalat, Vincent</creator><creator>Liebeskind, David S</creator><creator>Albers, Gregory W</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20220115</creationdate><title>Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis</title><author>Jovin, Tudor G ; Nogueira, Raul G ; Lansberg, Maarten G ; Demchuk, Andrew M ; Martins, Sheila O ; Mocco, J ; Ribo, Marc ; Jadhav, Ashutosh P ; Ortega-Gutierrez, Santiago ; Hill, Michael D ; Lima, Fabricio O ; Haussen, Diogo C ; Brown, Scott ; Goyal, Mayank ; Siddiqui, Adnan H ; Heit, Jeremy J ; Menon, Bijoy K ; Kemp, Stephanie ; Budzik, Ron ; Urra, Xabier ; Marks, Michael P ; Costalat, Vincent ; Liebeskind, David S ; Albers, Gregory W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-bc596232d5bf14cecb73b0416e5389b0ee43c294574bb9e457c665d17414a9e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Activities of daily living</topic><topic>Age</topic><topic>Cardiovascular system</topic><topic>Cerebral blood flow</topic><topic>Cerebral Hemorrhage - epidemiology</topic><topic>Cerebral Hemorrhage - etiology</topic><topic>Cerebral infarction</topic><topic>Clinical medicine</topic><topic>Clinical trials</topic><topic>Data analysis</topic><topic>Endovascular Procedures - adverse effects</topic><topic>Endovascular Procedures - methods</topic><topic>Endovascular Procedures - statistics & numerical data</topic><topic>Estimates</topic><topic>Gender</topic><topic>Health services</topic><topic>Hemorrhage</topic><topic>Heterogeneity</topic><topic>Humans</topic><topic>Ischemia</topic><topic>Meta-analysis</topic><topic>Mortality</topic><topic>Occlusion</topic><topic>Patients</topic><topic>Postoperative Hemorrhage - epidemiology</topic><topic>Postoperative Hemorrhage - etiology</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Stroke</topic><topic>Subgroups</topic><topic>Systematic review</topic><topic>Thrombectomy - adverse effects</topic><topic>Thrombectomy - methods</topic><topic>Thrombectomy - statistics & numerical data</topic><topic>Thrombotic Stroke - mortality</topic><topic>Thrombotic Stroke - surgery</topic><topic>Time-to-Treatment</topic><topic>Treatment Outcome</topic><topic>Windows (intervals)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jovin, Tudor G</creatorcontrib><creatorcontrib>Nogueira, Raul G</creatorcontrib><creatorcontrib>Lansberg, Maarten G</creatorcontrib><creatorcontrib>Demchuk, Andrew M</creatorcontrib><creatorcontrib>Martins, Sheila O</creatorcontrib><creatorcontrib>Mocco, J</creatorcontrib><creatorcontrib>Ribo, Marc</creatorcontrib><creatorcontrib>Jadhav, Ashutosh P</creatorcontrib><creatorcontrib>Ortega-Gutierrez, Santiago</creatorcontrib><creatorcontrib>Hill, Michael D</creatorcontrib><creatorcontrib>Lima, Fabricio O</creatorcontrib><creatorcontrib>Haussen, Diogo C</creatorcontrib><creatorcontrib>Brown, Scott</creatorcontrib><creatorcontrib>Goyal, Mayank</creatorcontrib><creatorcontrib>Siddiqui, Adnan H</creatorcontrib><creatorcontrib>Heit, Jeremy J</creatorcontrib><creatorcontrib>Menon, Bijoy K</creatorcontrib><creatorcontrib>Kemp, Stephanie</creatorcontrib><creatorcontrib>Budzik, Ron</creatorcontrib><creatorcontrib>Urra, Xabier</creatorcontrib><creatorcontrib>Marks, Michael P</creatorcontrib><creatorcontrib>Costalat, Vincent</creatorcontrib><creatorcontrib>Liebeskind, David S</creatorcontrib><creatorcontrib>Albers, Gregory W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jovin, Tudor G</au><au>Nogueira, Raul G</au><au>Lansberg, Maarten G</au><au>Demchuk, Andrew M</au><au>Martins, Sheila O</au><au>Mocco, J</au><au>Ribo, Marc</au><au>Jadhav, Ashutosh P</au><au>Ortega-Gutierrez, Santiago</au><au>Hill, Michael D</au><au>Lima, Fabricio O</au><au>Haussen, Diogo C</au><au>Brown, Scott</au><au>Goyal, Mayank</au><au>Siddiqui, Adnan H</au><au>Heit, Jeremy J</au><au>Menon, Bijoy K</au><au>Kemp, Stephanie</au><au>Budzik, Ron</au><au>Urra, Xabier</au><au>Marks, Michael P</au><au>Costalat, Vincent</au><au>Liebeskind, David S</au><au>Albers, Gregory W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2022-01-15</date><risdate>2022</risdate><volume>399</volume><issue>10321</issue><spage>249</spage><epage>258</epage><pages>249-258</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><abstract>Trials examining the benefit of thrombectomy in anterior circulation proximal large vessel occlusion stroke have enrolled patients considered to have salvageable brain tissue, who were randomly assigned beyond 6 h and (depending on study protocol) up to 24 h from time last seen well. We aimed to estimate the benefit of thrombectomy overall and in prespecified subgroups through individual patient data meta-analysis.
We did a systematic review and individual patient data meta-analysis between Jan 1, 2010, and March 1, 2021, of randomised controlled trials of endovascular stroke therapy. In the Analysis Of Pooled Data From Randomized Studies Of Thrombectomy More Than 6 Hours After Last Known Well (AURORA) collaboration, the primary outcome was disability on the modified Rankin Scale (mRS) at 90 days, analysed by ordinal logistic regression. Key safety outcomes were symptomatic intracerebral haemorrhage and mortality within 90 days.
Patient level data from 505 individuals (n=266 intervention, n=239 control; mean age 68·6 years [SD 13·7], 259 [51·3%] women) were included from six trials that met inclusion criteria of 17 screened published randomised trials. Primary outcome analysis showed a benefit of thrombectomy with an unadjusted common odds ratio (OR) of 2·42 (95% CI 1·76–3·33; p<0·0001) and an adjusted common OR (for age, gender, baseline stroke severity, extent of infarction on baseline head CT, and time from onset to random assignment) of 2·54 (1·83–3·54; p<0·0001). Thrombectomy was associated with higher rates of independence in activities of daily living (mRS 0–2) than best medical therapy alone (122 [45·9%] of 266 vs 46 [19·3%] of 238; p<0·0001). No significant difference between intervention and control groups was found when analysing either 90-day mortality (44 [16·5%] of 266 vs 46 [19·3%] of 238) or symptomatic intracerebral haemorrhage (14 [5·3%] of 266 vs eight [3·3%] of 239). No heterogeneity of treatment effect was noted across subgroups defined by age, gender, baseline stroke severity, vessel occlusion site, baseline Alberta Stroke Program Early CT Score, and mode of presentation; treatment effect was stronger in patients randomly assigned within 12–24 h (common OR 5·86 [95% CI 3·14–10·94]) than those randomly assigned within 6–12 h (1·76 [1·18–2·62]; pinteraction=0·0087).
These findings strengthen the evidence for benefit of endovascular thrombectomy in patients with evidence of reversible cerebral ischaemia across the 6–24 h time window and are relevant to clinical practice. Our findings suggest that in these patients, thrombectomy should not be withheld on the basis of mode of presentation or of the point in time of presentation within the 6–24 h time window.
Stryker Neurovascular.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34774198</pmid><doi>10.1016/S0140-6736(21)01341-6</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2022-01, Vol.399 (10321), p.249-258 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2597814656 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Activities of daily living Age Cardiovascular system Cerebral blood flow Cerebral Hemorrhage - epidemiology Cerebral Hemorrhage - etiology Cerebral infarction Clinical medicine Clinical trials Data analysis Endovascular Procedures - adverse effects Endovascular Procedures - methods Endovascular Procedures - statistics & numerical data Estimates Gender Health services Hemorrhage Heterogeneity Humans Ischemia Meta-analysis Mortality Occlusion Patients Postoperative Hemorrhage - epidemiology Postoperative Hemorrhage - etiology Randomized Controlled Trials as Topic Stroke Subgroups Systematic review Thrombectomy - adverse effects Thrombectomy - methods Thrombectomy - statistics & numerical data Thrombotic Stroke - mortality Thrombotic Stroke - surgery Time-to-Treatment Treatment Outcome Windows (intervals) |
| title | Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A22%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thrombectomy%20for%20anterior%20circulation%20stroke%20beyond%206%20h%20from%20time%20last%20known%20well%20(AURORA):%20a%20systematic%20review%20and%20individual%20patient%20data%20meta-analysis&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Jovin,%20Tudor%20G&rft.date=2022-01-15&rft.volume=399&rft.issue=10321&rft.spage=249&rft.epage=258&rft.pages=249-258&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(21)01341-6&rft_dat=%3Cproquest_cross%3E2597814656%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2619518568&rft_id=info:pmid/34774198&rft_els_id=S0140673621013416&rfr_iscdi=true |